{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:34:32Z","timestamp":1791221672489,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T00:00:00Z","timestamp":1335312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034833","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T17:26:16Z","timestamp":1335547576000},"page":"e34833","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":150,"title":["Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans"],"prefix":"10.1371","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct00059605","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Charles","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jack","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajagopal","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitanjali","family":"Jayachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall E.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerabhadran","family":"Baladandayuthapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy S.","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"McMannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(91)90636-D","article-title":"Molecular themes in oncogenesis.","volume":"64","author":"J Bishop","year":"1991","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature03098","article-title":"Intrinsic tumour suppression.","volume":"432","author":"S Lowe","year":"2004","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/14712598.6.1.55","article-title":"Adenovirus p53 gene therapy.","volume":"6","author":"J Roth","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jnci\/91.9.763","article-title":"Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.","volume":"91","author":"S Swisher","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm0996-985","article-title":"Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.","volume":"2","author":"J Roth","year":"1996","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1200\/JCO.1998.16.6.2221","article-title":"Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.","volume":"16","author":"G Clayman","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref7","first-page":"6116","article-title":"The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes.","volume":"60","author":"M Lerman","year":"2000","journal-title":"Cancer Res"},{"key":"ref8","first-page":"2715","article-title":"Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.","volume":"62","author":"L Ji","year":"2002","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment.","volume":"47","author":"AB Miller","year":"1981","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-03-3702","article-title":"Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells.","volume":"64","author":"F Uno","year":"2004","journal-title":"Cancer Research"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1078-0432.CCR-07-1252","article-title":"Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer.","volume":"14","author":"L Prudkin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2307\/2531628","article-title":"Continual reassessment method: a practical design for phase 1 clinical trials in cancer.","volume":"46","author":"J O'Quigley","year":"1990","journal-title":"Biometrics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.onc.1202349","article-title":"Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.","volume":"18","author":"II Wistuba","year":"1999","journal-title":"Oncogene"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14796694.1.1.79","article-title":"3p21.3 tumor suppressor cluster: prospects for translational applications.","volume":"1","author":"L Ji","year":"2005","journal-title":"Future Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-03-3702","article-title":"Myristoylation of the Fus1 protein is required for tumor suppression in human lung cancer cells.","volume":"64","author":"F Uno","year":"2004","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1541-7786.MCR-08-0507","article-title":"miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.","volume":"7","author":"L Du","year":"2009","journal-title":"Mol Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.","volume":"464","author":"ME Davis","year":"2010","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.","volume":"26","author":"A Puri","year":"2009","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/sj.gt.3300485","article-title":"Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA.","volume":"4","author":"J Yang","year":"1997","journal-title":"Gene Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nbt0797-647","article-title":"Improved DNA: liposome complexes for increased systemic delivery and gene expression.","volume":"15","author":"N Templeton","year":"1997","journal-title":"Nat Biotech"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/hum.2005.16.1087","article-title":"Reversible mode of binding of serum proteins to DOTAP\/cholesterol Lipoplexes: a possible explanation for intravenous lipofection efficiency.","volume":"16","author":"D Simberg","year":"2005","journal-title":"Hum Gene Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1073\/pnas.0610298104","article-title":"Biomimetic amplification of nanoparticle homing to tumors.","volume":"104","author":"D Simberg","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/hum.1996.7.9-1111","article-title":"In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells.","volume":"7","author":"I Aksentijevich","year":"1996","journal-title":"Hum Gene Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1525-0016(03)00004-2","article-title":"Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration.","volume":"7","author":"I Ito","year":"2003","journal-title":"Mol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/mthe.2001.0266","article-title":"Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.","volume":"3","author":"R Ramesh","year":"2001","journal-title":"Mol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.cgt.7700756","article-title":"Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.","volume":"11","author":"I Ito","year":"2004","journal-title":"Cancer Gene Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.gt.3301640","article-title":"Potential limitations of transcription terminators used as transgene insulators in adenoviral vectors.","volume":"9","author":"M Buvoli","year":"2002","journal-title":"Gene Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/nar\/20.9.2233","article-title":"Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector.","volume":"20","author":"G Wilkinson","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(83)90012-0","article-title":"The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.","volume":"33","author":"P Hearing","year":"1983","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.gt.3301097","article-title":"Bacterial DNA is implicated in the inflammatory response to delivery of DNA\/DOTAP to mouse lungs.","volume":"7","author":"G McLachlan","year":"2000","journal-title":"Gene Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1089\/10430340050207984","article-title":"Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice.","volume":"11","author":"J Tousignant","year":"2000","journal-title":"Hum Gene Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/gt.2010.97","article-title":"Identification and removal of colanic acid from plasmid DNA preparations: implications for gene therapy.","volume":"17","author":"P Firozi","year":"2010","journal-title":"Gene Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JTO.0b013e31816bce65","article-title":"Tumor suppressor FUS1 signaling pathway.","volume":"3","author":"L Ji","year":"2008","journal-title":"J Thorac Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/0008-5472.CAN-06-3463","article-title":"Synergistic tumor suppression by coexpression of FUS1 and p53 Is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.","volume":"67","author":"W Deng","year":"2007","journal-title":"Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:58:42Z","timestamp":1588967922000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034833"}},"subtitle":[],"editor":[{"given":"Masaru","family":"Katoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,25]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034833","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.715898029.791452808","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,25]]}}}